Trial
NCT02971033
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
—
Condition
Chronic Hepatitis C
Intervention
20mg ezetimibe
Why stopped
Study Funding ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-06